The role of NF-κB in 6-hydroxydopamine- and TNFα-induced apoptosis of PC12 cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 6, 2004, Pages 563-569

  Tarabin, Victoria ^a   Schwaninger, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

6 Hydroxydopamine; Gene transcription; Neurodegeneration; NF B; Parkinson's disease; TNF

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; OXIDOPAMINE; SERINE DERIVATIVE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOXYCYCLINE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL STRAIN; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; NONHUMAN; ONCOGENE C MYC; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PHEOCHROMOCYTOMA CELL; RAT; REPORTER GENE; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; PHYSIOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; APOPTOSIS; DOXYCYCLINE; I-KAPPA B PROTEINS; NF-KAPPA B; OXIDOPAMINE; PC12 CELLS; RATS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042545952     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0938-1     Document Type: Article

References (41)

1. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745-756
2. Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18:1175-1177
3. Beal MF (2001) Experimental models of Parkinson's disease. Nat Rev Neurosci 2:325-334
4. Beg A, Sha W, Bronson R, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170
5. Blum D, Torch S, Nissou MF, Verna JM (2001) 6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells. Biochem Pharmacol 62:473-481
6. Borrello S, Demple B (1997) NF kappa B-independent transcriptional induction of the human manganous superoxide dismutase gene. Arch Biochem Biophys 348:289-294
7. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW (1995) Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 15:2809-2818
8. Curtius HC, Wolhensberger M, Steinmann B, Redweik S (1974) Mass fragmentography of dopamine and 6-OH-dopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr 99:529-540
9. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822
10. De Erausquin GA, Hyrc K, Dorsey DA, Mamah D, Dokucu M, Masco DH, Walton T, Dikranian K, Soriano M, Garcia Verdugo JM, Goldberg MP, Dugan LL (2003) Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons. Mol Pharmacol 63:784-790
11. Duyao MP, Buckler AJ, Sonenshein GE (1990) Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci USA 87:4727-4731
12. Erlandsson N, Baumann B, Rössler OG, Kaufmann K, Giehl KM, Wirth T, Thiel G (2002) Lack of correlation between NF-κB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940. Biochem Pharmacol 64:487-495
13. Ghribi O, Herman MM, Pramoonjago P, Savory J (2003) MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-κB signaling pathways. J Neuropathol Exp Neurol 62:1144-1153
14. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551
15. Haviv R, Stein R (1999) Nerve growth factor inhibits apoptosis induced b tumor necrosis factor in PC12 cells. J Neurosci Res 55:269-277
16. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, Kikugawa K (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22:3356-3366
17. Herrmann O, Tarabin V, Suzuki S, Attigah N, Prinz S, Schneider A, Coserea I, Monyer H, Brombacher F, Schwaninger M (2003) Regulation of body temperature and neuroprotection by endogenous interleukin-6 in focal cerebral ischemia. J Cereb Blood Flow Metab 23:406-415
18. Holtz WA, O'Malley KL (2003) Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278:19367-19377
19. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA 94:7531-7536
20. Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Droge W, Schmitz ML (2000) The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem 267:3828-3835
21. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227
22. Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3:17-26
23. Kiningham KK, Xu Y, Daosukho C, Popova B, St Clair DK (2001) Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem J 353:147-156
24. Levites Y, Youdim MBH, Maor G, Mandel S (2002) Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappa (NF-κB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21-29
25. Mielke K, Herdegen T (2002) Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFalpha-mediated apoptosis in neuronlike, but not naive, PC12 cells. Mol Cell Neurosci 20:211-224
26. Nass R, Blakely RD (2003) The caenorhabditis elegans dopaminergic system: opportunities for insight into dopamine transport and neurodegeneration. Annu Rev Pharmacol Toxicol 43:521-544
27. Packham G, Cleveland JL (1995) c-Myc and apoptosis. Biochim Biophys Acta 1242:11-28
28. Panet H, Barzilai A, Daily D, Melamed E, Offen D (2001) Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J Neurochem 77:391-398
29. Pizzi M, Goffi F, Boroni F, Benarese M, Perkins SE, Liou HC, Spano P (2002) Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J Biol Chem 277:20717-20723
30. Roshak AK, Jackson JR, McGough K, Chabot-Fletcher M, Mochan E, Marshall LA (1996) Manipulation of distinct NFkappaB proteins alters interleukin-1beta- induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J Biol Chem 271:31496-31501
31. Ryan KM, Ernst MK, Rice NR, Vousden KH (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404:892-897
32. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22:10690-10698
33. Sallmann S, Juttler E, Prinz S, Petersen N, Knopf U, Weiser T, Schwaninger M (2000) Induction of interleukin-6 by depolarization of neurons. J Neurosci 20:8637-8642
34. Scholzke MN, Potrovita I, Subramaniam S, Prinz S, Schwaninger M (2003) Glutamate activates NF-kappaB through calpain in neurons. Eur J Neurosci 18:3305-3310
35. Schwaninger M, Sallmann S, Petersen N, Schneider A, Prinz S, Libermann TA, Spranger M (1999) Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB. J Neurochem 73:1461-1466
36. Senoh S, Creveling CR, Udenfriend S, Witkop B (1959) Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine. J Am Chem Soc 81:6236-6240
37. Teismann P, Schwaninger M, Weih F, Ferger B (2001) Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease. Neuroreport 12:1049-1053
38. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789
39. Walkinshaw G, Waters CM (1994) Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63:975-987
40. Wang X, Qin ZH, Leng Y, Wang Y, Jin X, Chase TN, Bennett MC (2002) Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells. J Neurochem 83:1094-1102
41. Wong GH, Elwell JH, Oberley LW, Goeddel DV (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931